Background Despite the implementation and expansion of public health and harm reduction
strategies aimed at preventing and reversing overdoses, rates of overdose-related events …

We sought to evaluate the rates and predictors of SARS-CoV-2 vaccination among members
of a structurally-marginalized population of people who use drugs (PWUD) during a …

Introduction: Opioid use disorder (OUD) is a critical health issue in the USA. Pennsylvania
has the third highest number of drug overdose deaths per year, with the COVID-19 …

Background The distribution of resources during the COVID-19 pandemic has been
politicized and contentious in the United States. Vulnerable populations, such as those living …

Introduction Stigmatization of people with substance use problems have been reported to be
high among young adults in Western countries. It is not clear if this finding could be …

Objective It is unclear how healthcare professionals (HCPs) experience and view the
challenges of working with people who use New Psychoactive Substances (PWUNPS), in …

Background: The unprecedented first wave of the COVID-19 pandemic severely impacted
mental health services globally. However, the negative impact of such disruptions on people …

Objectives. To assess heterogeneity in pandemic-period excess fatal overdoses in the
United States, by location (state, county) and substance type. Methods. We used seasonal …

As the chapters of this book have outlined from several perspectives, the stigma surrounding
substance use disorders (SUDs) has detrimental effects on people who use substances …

Background In the context of changing cannabis and other drug policy and regulation,
concerns may arise regarding drug treatment access and use. We assessed …